1800 202 8726
Before major GI surgery

PET-CT Before — Liver Surgery or HIPEC

Before liver resection or HIPEC, a PET-CT scan looks for cancer spread that CT alone may not show. If it finds disease beyond what surgery can address, the team has time to change the plan — before the operation, not during it.

Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed September 2026

  • Prevents futile surgery — PET can reveal cancer that CT missed before a major operation is booked.
  • Active disease, not just tumour size — PET detects how fast cells are consuming glucose, which CT does not show.
  • Known blind spots — Mucinous and low-grade GI tumours may not show clearly on PET even when disease is present.
  • Part of a larger workup — PET is one piece of the staging picture — diagnostic laparoscopy and MRI fill gaps that PET cannot.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Get this explained properly

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

A PET-CT before liver resection or HIPEC checks for cancer spread beyond what CT alone shows. If new disease is found, your team may change or postpone surgery to avoid an operation that cannot achieve its goal. PET has known blind spots for certain tumour types — your team will explain whether these apply to you.

At CION, a whole-body PET-CT starts from Rs 10,499 — among the lowest published prices in Hyderabad. Indicative price, as of September 2026.

Why does your surgeon order a PET scan before liver surgery or HIPEC?

Both liver resection and HIPEC are major operations, and they are only worthwhile when clearing all visible cancer is a realistic goal. If cancer has spread somewhere that surgery cannot reach, the operation cannot achieve that goal — and knowing this before surgery, rather than during it, is what matters.

A standard CT scan shows the size and position of tumours but can miss small clusters of active cancer elsewhere in the body. PET-CT detects how fast cells are consuming glucose, which can reveal deposits that CT has not shown — including in lymph nodes, distant organs, or other parts of the abdomen.

ASCO and ESMO guidance for colorectal cancer staging includes PET-CT in the preoperative workup for selected patients before hepatic resection, specifically for its ability to detect extrahepatic disease that changes the surgical plan.

Can the PET scan change your surgical plan?

Yes, and that is its purpose. In a proportion of patients who appear operable on CT alone, PET identifies disease that had not previously been visible. When that happens, the plan is reviewed before you go to theatre.

A positive finding does not automatically rule out surgery. Your team will assess what was found and where, and decide whether to proceed, to give systemic treatment first, or to investigate further.

A negative PET does not guarantee the absence of disease. It means no site of significant metabolic activity was detected at the time of the scan. Your team will explain what the result means for your specific plan.

Still unclear?

Send your reports across and a specialist will walk you through what they mean — what is known, what is not, and what the options actually are.

PET-CT Partner Centres

PET-CT Scan Centres in Hyderabad

CION offers PET-CT scans through 4 trusted partner PET-CT centres across Hyderabad, so you can choose the one closest to you. Call 18002028726 and we’ll guide you to the earliest available appointment.

These are partner diagnostic centres within the CION network. Toll-free booking: 18002028726.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Get a straight answer from a specialist

45 minutes, your reports reviewed, your questions answered in plain language.

Book Free Consultation Call 1800 202 8726

What does PET-CT miss in GI and liver cancer?

PET works by detecting high glucose uptake in cells. Some tumours consume glucose at lower rates, so they appear dim or normal on PET even when active disease is present. This is a well-established limitation, not a scanner failure.

Mucinous tumours — including mucinous colorectal carcinoma and appendiceal mucinous neoplasms, which are among the cancers most often referred for HIPEC — are known to show low FDG uptake. In these tumours, a normal-looking PET does not rule out peritoneal disease. If your tumour is mucinous, your team should tell you explicitly that this limitation applies to you.

Low-grade GI tumours share this limitation. Small peritoneal deposits below PET's spatial resolution may not appear on FDG imaging. Diagnostic laparoscopy remains part of the staging workup before HIPEC in many centres for precisely this reason.

Questions about the PET scan and your surgical workup

When in the treatment timeline is the PET scan done?

Usually after the diagnosis has been confirmed and baseline imaging completed, and before the surgical plan is finalised. Timing matters — a PET done during active chemotherapy may underestimate disease because treatment suppresses metabolic activity. If you have recently finished a chemotherapy cycle, your team will advise whether to wait before scanning. Results are reviewed in a multidisciplinary meeting before your surgical date is confirmed.

Will I need a new PET if I had one earlier in my treatment?

Possibly. A PET done months earlier, or before a course of chemotherapy, describes the disease at that point in time. Before major surgery, your team needs to know the current state — whether the cancer has remained stable, responded, or progressed. If your most recent PET is recent and your treatment has not changed since, your team may decide it is still valid. If there is any doubt, a repeat scan is the safer starting point.

What happens if the PET finds something unexpected?

Your case will be discussed again in a multidisciplinary team meeting, which typically includes your oncologist, surgeon, radiologist, and a nuclear medicine specialist. The finding is assessed for whether it is likely to be cancer, whether it can be biopsied, and what it means for the surgical plan. In some cases, additional imaging is ordered first. You will be told clearly what the finding means before any decision is made, and you will have the opportunity to ask questions.

Is HIPEC still possible if my tumour is mucinous?

HIPEC may still be considered for mucinous tumours, but the staging workup is more demanding precisely because PET is less reliable for this tumour type. Diagnostic laparoscopy — a keyhole surgical inspection of the abdomen — is frequently used alongside or instead of PET to assess the extent of peritoneal disease before HIPEC is confirmed as the plan. Your team will explain which staging steps apply to you. The decision depends on the extent of disease and your fitness for major surgery, not on the PET result alone.

How close to surgery is the PET scan usually done?

Generally close enough to the surgical date that the result reflects your current disease status, but with enough time for the multidisciplinary team to review it and adjust the plan if needed. The exact interval depends on your centre's scheduling and on whether any findings require further investigation. If your surgery date is pushed back significantly after the PET is done, ask your team whether a repeat scan is needed before you proceed.

Did you know?

Preoperative PET-CT identifies extrahepatic disease not detected on CT in a proportion of patients considered operable for colorectal liver metastases — enough that ASCO and ESMO guidance specifically includes it in the staging workup before hepatic resection for selected patients.

The finding that most commonly changes the plan is extrahepatic spread: disease in lymph nodes or distant organs that surgery on the liver alone cannot address.

Source: ASCO / ESMO Colorectal Cancer Clinical Practice Guidelines

PET-CT at CION starts from Rs 10,499 — among the lowest published prices in Hyderabad — across 4 partner centres in Banjara Hills, Punjagutta, Himayatnagar and Narayanaguda. Indicative price, as of September 2026.

Explore 100 more PET-CT for Your Cancer Type topics

All PET-CT for Your Cancer Type →

Your next step

Talk to an oncologist about your scan

Your PET-CT report read by a senior oncologist, explained in plain language, with a free 45-minute consultation.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

What is HIPEC and why does it need a PET scan beforehand?

HIPEC (hyperthermic intraperitoneal chemotherapy) is a procedure in which heated chemotherapy is circulated through the abdomen during surgery to treat cancer that has spread to the peritoneal lining. It is a major operation, usually combined with surgery to remove visible deposits. PET-CT is done beforehand to check for spread beyond the abdomen that the combined surgery cannot address. If distant disease is found, the team may reconsider or change the plan before you go to theatre.

Can PET-CT tell exactly how far the cancer has spread in the abdomen?

Not with complete accuracy. PET shows metabolically active disease but has spatial resolution limits — small peritoneal deposits may not appear. Diagnostic laparoscopy, a direct keyhole inspection of the abdominal lining, gives more precise peritoneal staging than any scan. PET and laparoscopy are often used together in the workup before HIPEC, not as alternatives to each other.

My tumour is mucinous — does that make the PET less useful for me?

Yes, to an important degree. Mucinous tumours produce less FDG uptake, so PET is less sensitive at detecting them. A normal-looking PET does not mean the cancer has not spread — it may simply not be showing clearly. Your team will rely more heavily on CT, MRI, and diagnostic laparoscopy for staging, and may still order a PET to look for distant sites that would change the overall plan.

Does a negative PET mean I am definitely clear to have surgery?

A negative PET is one piece of the picture, not a guarantee that no disease is present. It means no site of significant metabolic activity was detected at the time of the scan. It does not rule out small deposits below the scanner's resolution, or disease in tumour types with low glucose uptake. Your team will use the PET result alongside CT, MRI, clinical assessment, and sometimes laparoscopy before confirming the surgical plan.

Will the PET scan be done at CION?

PET-CT is coordinated with partner imaging centres rather than performed at CION centres directly. Your team will arrange this as part of your preoperative workup and will review the results in a multidisciplinary meeting before your surgical plan is confirmed. If you have a preference for which imaging centre you use, discuss this with your care coordinator early.

What should I ask before my PET scan?

Ask whether your tumour type is known to show low FDG uptake on PET, and what the team will rely on if the result is negative. Ask whether you need to wait after a chemotherapy cycle before the scan is done. Ask when the results will be reviewed and when you will hear about the outcome. These questions help you understand what the scan can and cannot tell you before you have it.

Call now Book free consultation